Risks of SARS-CoV-2 JN.1 Infection and COVID-19–Associated Emergency-Department Visits or Hospitalizations Following Updated Boosters and Prior Infection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Risks of SARS-CoV-2 JN.1 infection and COVID-19 associated emergency-department (ED) visits/hospitalizations following updated boosters and prior infection: a population-based cohort study
Clin. Infect. Dis. 2024 Jun 26;[EPub Ahead of Print], C Chong, LE Wee, X Jin, M Zhang, MIA Malek, B Ong, D Lye, CJ Chiew, KB TanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.